Key Metrics
11.43
Heat Index-
Impact LevelMedium
-
Scope LevelNational
-
Last Update2026-04-23
Key Impacts
Positive Impacts (9)
Cannabis multi-state operators (MSOs)
U.S. cannabis operators
Cannabis biotechnology and pharmaceutical companies
DEA-regulated research supply chain
Ancillary cannabis suppliers
REITs focused on cannabis facilities
Total impacts: 9 |
Positive: 9 |
Negative: 0
Event Overview
This policy shift reclassifies state-licensed medical marijuana, indicating a significant change in federal drug policy. The move signals a potential easing of restrictions and acknowledges the medicinal value of cannabis.
Collect Records
US Acting Attorney General Orders Reclassification of Medical Marijuana
2026-04-24 03:08
On April 23, the acting U.S. Attorney General Todd Bland ordered the reclassification of state-licensed medical marijuana from Schedule I to Schedule III under the Controlled Substances Act. This change marks one of the most significant shifts in federal marijuana policy in fifty years.
Total records: 1